Clinical Trial Update: Study of Telitacicept in Generalized Myasthenia Gravis [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating Telitacicept in generalized myasthenia gravis has completed, according to the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis Generalized

Drugs mentioned

• Telitacicept

Snippet

Sponsor: RemeGen Co., Ltd. | Conditions: Myasthenia Gravis, Generalized | Phase 3 | Status: COMPLETED